EFFECT OF ONO-5334, A NOVEL CATHEPSIN K INHIBITOR, ON BONE TURNOVER MARKERS IN CYNOMOLGUS MONKEYS

被引：0
|
作者：
Mori, H. [1 ]
Yamada, H. [1 ]
Kunishige, A. [1 ]
Nishikawa, S. [1 ]
Hashimoto, Y. [1 ]
Tanaka, M. [1 ]
Shiroya, T. [1 ]
机构：
[1] Ono Pharmaceut Co Ltd, Dev Res Labs, Osaka, Japan
来源：
OSTEOPOROSIS INTERNATIONAL | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：336 / 336
页数：1
相关论文
共 50 条
  • [1] Efficacy of ONO-5334, a cathepsin K inhibitor, on bone turnover and cortical geometry in ovariectomized cynomolgus monkeys
    Ochi, Y.
    Yamada, H.
    Kunishige, A.
    Nishikawa, S.
    Hashimoto, Y.
    Mori, H.
    Sugitani, M.
    Kawabata, K.
    BONE, 2011, 48 : S72 - S72
  • [2] Efficacy of ONO-5334, a cathepsin K inhibitor, on bone mass and strength in ovariectomized cynomolgus monkeys
    Yamada, H.
    Ochi, Y.
    Kunishige, A.
    Nishikawa, S.
    Hashimoto, Y.
    Mori, H.
    Sugitani, M.
    Kawabata, K.
    BONE, 2011, 48 : S221 - S221
  • [3] Effects of the Cathepsin K Inhibitor ONO-5334 and Concomitant Use of ONO-5334 with Methotrexate on Collagen-Induced Arthritis in Cynomolgus Monkeys
    Yamada, Hiroyuki
    Mori, Hiroshi
    Nakanishi, Yasutomo
    Nishikawa, Satoshi
    Hashimoto, Yasuaki
    Ochi, Yasuo
    Tanaka, Makoto
    Kawabata, Kazuhito
    INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2019, 2019
  • [4] EFFECTS OF THE NOVEL CATHEPSIN K INHIBITOR, ONO-5334, ON BONE TURNOVER MARKERS IN POSTMENOPAUSAL WOMEN: A MULTIPLE DOSE PHASE I STUDY
    Nagase, S.
    Ohyama, M.
    Small, M.
    Kuwayama, T.
    Deacon, S.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 338 - 338
  • [5] Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys
    Yamada, Hiroyuki
    Ochi, Yasuo
    Mori, Hiroshi
    Nishikawa, Satoshi
    Hashimoto, Yasuaki
    Nakanishi, Yasutomo
    Tanaka, Makoto
    Bruce, Mark
    Deacon, Steve
    Kawabata, Kazuhito
    BONE, 2016, 86 : 43 - 52
  • [6] Effects of eight-month treatment with ONO-5334, a cathepsin K inhibitor, on bone metabolism, strength and microstructure in ovariectomized, cynomolgus monkeys
    Ochi, Yasuo
    Yamada, Hiroyuki
    Mori, Hiroshi
    Nakanishi, Yasutomo
    Nishikawa, Satoshi
    Kayasuga, Ryoji
    Kawada, Naoki
    Kunishige, Akiko
    Hashimoto, Yasuaki
    Tanaka, Makoto
    Sugitani, Masafumi
    Kawabata, Kazuhito
    BONE, 2014, 65 : 1 - 8
  • [7] Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism
    Ochi, Yasuo
    Yamada, Hiroyuki
    Mori, Hiroshi
    Nakanishi, Yasutomo
    Nishikawa, Satoshi
    Kayasuga, Ryoji
    Kawada, Naoki
    Kunishige, Akiko
    Hashimoto, Yasuaki
    Tanaka, Makoto
    Sugitani, Masafumi
    Kawabata, Kazuhito
    BONE, 2011, 49 (06) : 1351 - 1356
  • [8] The Effect of the Cathepsin K Inhibitor ONO-5334 on Trabecular and Cortical Bone in Postmenopausal Osteoporosis: The OCEAN Study
    Engelke, Klaus
    Nagase, Shinichi
    Fuerst, Thomas
    Small, Maria
    Kuwayama, Tomohiro
    Deacon, Stephen
    Eastell, Richard
    Genant, Harry K.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (03) : 629 - 638
  • [9] Increased cortical bone mass by treatment with ONO-5334, a cathepsin K inhibitor, is associated with high bone strength compared to alendronate in ovariectomized monkeys
    Mori, H.
    Ochi, Y.
    Yamada, H.
    Nakanishi, Y.
    Nishikawa, S.
    Hashimoto, Y.
    Sugitani, M.
    Kawabata, K.
    BONE, 2012, 50 : S157 - S157
  • [10] Bone turnover markers and pharmacokinetics of a new sustained-release formulation of the cathepsin K inhibitor, ONO-5334, in healthy post-menopausal women
    Nagase, Shinichi
    Ohyama, Michiyo
    Hashimoto, Yoshitaka
    Small, Maria
    Sharpe, John
    Manako, Junichiro
    Kuwayama, Tomohiro
    Deacon, Steve
    JOURNAL OF BONE AND MINERAL METABOLISM, 2015, 33 (01) : 93 - 100
12345